HomeZTS • NYSE
add
Zoetis Inc
Previous close
$160.35
Day range
$160.20 - $163.24
Year range
$139.70 - $200.33
Market cap
72.59B USD
Avg Volume
3.31M
P/E ratio
29.28
Dividend yield
1.23%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.22B | 1.37% |
Operating expense | 752.00M | 0.80% |
Net income | 631.00M | 5.34% |
Net profit margin | 28.42 | 3.91% |
Earnings per share | 1.48 | 7.25% |
EBITDA | 965.00M | 4.10% |
Effective tax rate | 22.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.74B | -11.85% |
Total assets | 14.10B | -1.74% |
Total liabilities | 9.44B | 1.58% |
Total equity | 4.66B | — |
Shares outstanding | 445.21M | — |
Price to book | 15.36 | — |
Return on assets | 14.93% | — |
Return on capital | 18.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 631.00M | 5.34% |
Cash from operations | 587.00M | -1.34% |
Cash from investing | -175.00M | -33.59% |
Cash from financing | -677.00M | -29.20% |
Net change in cash | -266.00M | -303.03% |
Free cash flow | 362.00M | -16.66% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
13,800
